Fate Therapeutics (FATE) Net Equity Issued and Repurchased (2012 - 2024)
Fate Therapeutics' Net Equity Issued and Repurchased was $74.53 million in FY2024, compared with $85,000 in FY2023.
Powered by 
Analysis
Fate Therapeutics (FATE) Net Equity Issued and Repurchased (2012 - 2024) Analysis & Trends
From FY2011 onward, Fate Therapeutics has reported Net Equity Issued and Repurchased for 14 years.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -14.4% (FY2019 to FY2024).
- The FY2024 figure marks the highest annual Net Equity Issued and Repurchased since FY2019.
- Per Business Quant data, Net Equity Issued and Repurchased in earlier years was $85,000 in FY2023 (-99.1%), $9.21 million in FY2022 (-55.6%), $20.71 million in FY2021 (-58.6%) and $49.98 million in FY2020 (-69.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Fate Therapeutics | 276.57 Mn | 276.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -662,000.00 |
| Mar 31, 2024 | 75.19 Mn |
| Dec 31, 2023 | -180,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 207,000.00 |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 11.36 Mn |
| Jun 30, 2021 | 3.72 Mn |
| Mar 31, 2021 | 5.61 Mn |
| Dec 31, 2020 | -138.81 Mn |
| Sep 30, 2020 | -270,000.00 |
| Jun 30, 2020 | 188.04 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | -136,000.00 |
| Sep 30, 2019 | 160.60 Mn |
| Jun 30, 2019 | 688,000.00 |
API Access
Fate Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();